跳至主要内容
临床试验/JPRN-C000000077
JPRN-C000000077已完成2 期

Role of Thymidine Phosphorylase(TP), Dihydropyrimidine Dehydrogenase(DPD)and Thymidylate synthase(TS)for Predicting the Prognosis and Therapeutic Effects of Doxifluridine, An Intermediate form of Capecitabine, in adjuvant therapy for postoperative Node positive colorectal cancer(DukesC); Findings from a multicenter Phase2 trial. - Role of Thymidine Phosphorylase(TP), Dihydropyrimidine Dehydrogenase(DPD)and Thymidylate synthase(TS) in adjuvant therapy of Capecitabine for postoperative Node positive colorectal cancer(DukesC).

Multicenter Clinical Study Group of Osaka0 个研究点目标入组 300 人开始时间: 2006年1月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • appendiceal carcinoma and anal canal carcinoma of anal gland origin Multiple cancer patients except m cancer apparent infection sever postoperative complications active peptic ulcer Cardiac infarction within three months-uncontrolled hypertension -diabetes mellitus, uncontrolled or controlled with insulin -unstable angina, myocardial infarction needed to treat or febrile neutropenia

研究者

发起方
Multicenter Clinical Study Group of Osaka

相似试验